Evidence map›Paper›PMID 40128814›Full record

ArticleRespiratory research2025

Aging shapes infection profiles of influenza A virus and SARS-CoV-2 in human precision-cut lung slices.

Melanie Brügger, Carlos Machahua, Trix Zumkehr, Christiana Cismaru, Damian Jandrasits, Bettina Trüeb, Sara Ezzat, Blandina I Oliveira Esteves, Patrick Dorn, Thomas M Marti and 4 more

Abstract read
In one paragraph

Article in Respiratory research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. mBio · 2026
    Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Melanie BrüggerInstitute of Virology and Immunology, Bern, Switzerland. melanie.bruegger@unibe.ch.
Carlos MachahuaDepartment for Pulmonary Medicine, Allergology and Clinical Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Trix ZumkehrInstitute of Virology and Immunology, Bern, Switzerland.
Christiana CismaruInstitute of Virology and Immunology, Bern, Switzerland.
Damian JandrasitsInstitute of Virology and Immunology, Bern, Switzerland.
Bettina TrüebInstitute of Virology and Immunology, Bern, Switzerland.
Sara EzzatInstitute of Virology and Immunology, Bern, Switzerland.
Blandina I Oliveira EstevesInstitute of Virology and Immunology, Bern, Switzerland.
Patrick DornDepartment of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Thomas M MartiDepartment of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Gert ZimmerInstitute of Virology and Immunology, Bern, Switzerland.
Volker ThielInstitute of Virology and Immunology, Bern, Switzerland.
Manuela Funke-ChambourDepartment for Pulmonary Medicine, Allergology and Clinical Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Marco P AlvesInstitute of Virology and Immunology, Bern, Switzerland. marco.alves@unibe.ch.

Funding

Lungenliga Bern, Switzerland The impact of SARS-CoV-2 infection on the aged lung
6 · The paper itself

Abstract

backgroundThe coronavirus disease 2019 (COVID-19) outbreak revealed the susceptibility of elderly patients to respiratory virus infections, showing cell senescence or subclinical persistent inflammatory profiles and favoring the development of severe pneumonia.

methodsIn our study, we evaluated the potential influence of lung aging on the efficiency of replication of influenza A virus (IAV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as determining the pro-inflammatory and antiviral responses of the distal lung tissue.

resultsUsing precision-cut lung slices (PCLS) from donors of different ages, we found that pandemic H1N1 and avian H5N1 IAV replicated in the lung parenchyma with high efficacy. In contrast to these IAV strains, SARS-CoV-2 Early isolate and Delta variant of concern (VOC) replicated less efficiently in PCLS. Interestingly, both viruses showed reduced replication in PCLS from older compared to younger donors, suggesting that aged lung tissue represents a suboptimal environment for viral replication. Regardless of the age-dependent viral loads, PCLS responded to H5N1 IAV infection by an induction of IL-6 and IP10/CXCL10, both at the mRNA and protein levels, and to H1N1 IAV infection by induction of IP10/CXCL10 mRNA. Finally, while SARS-CoV-2 and H1N1 IAV infection were not causing detectable cell death, H5N1 IAV infection led to more cytotoxicity and induced significant early interferon responses.

conclusionsIn summary, our findings suggest that aged lung tissue might not favor viral dissemination, pointing to a determinant role of dysregulated immune mechanisms in the development of severe disease.

Indexed as

AgingCOVID-19Influenza A Virus, H1N1 SubtypeInfluenza A Virus, H5N1 SubtypeInfluenza, HumanLungSARS-CoV-2AdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedVirus ReplicationAgingDistal lungInfluenza virusPrecision-cut lung slicesSARS-CoV-2

Identifiers

PMID40128814
PMCPMC11934781

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.